Approval · Notice of Compliance 17101 · 2015
ZYCLARA: Notice of Compliance 17101
Issued July 17, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17101
- Date
- July 17, 2015
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate drug substance manufacturing site
- Therapeutic class
- Immune response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZYCLARA | Not yet assigned | — |